Azelnidipine protects myocardium in hyperglycemia-induced cardiac damage
<p>Abstract</p> <p>Background</p> <p>Azelnidipine (AZL), a long-acting dihydropyridine-based calcium antagonist, has been recently approved and used for treating ischemic heart disease and cardiac remodeling after myocardial infarction, however, its effect on hyperglyce...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-12-01
|
| Series: | Cardiovascular Diabetology |
| Online Access: | http://www.cardiab.com/content/9/1/82 |